ARZMX
Price
$16.29
Change
+$0.02 (+0.12%)
Updated
Nov 12 closing price
Net Assets
1.1B
SSGSX
Price
$46.37
Change
+$0.09 (+0.19%)
Updated
Nov 12 closing price
Net Assets
5.22B
Interact to see
Advertisement

ARZMX vs SSGSX

Header iconARZMX vs SSGSX Comparison
Open Charts ARZMX vs SSGSXBanner chart's image
AMG River Road Small Cap Value Z
Price$16.29
Change+$0.02 (+0.12%)
VolumeN/A
Net Assets1.1B
Victory Sycamore Small Company Opp A
Price$46.37
Change+$0.09 (+0.19%)
VolumeN/A
Net Assets5.22B
ARZMX vs SSGSX Comparison Chart in %
View a ticker or compare two or three
VS
ARZMX vs. SSGSX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARZMX is a Hold and SSGSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
SSGSX has more cash in the bank: 5.22B vs. ARZMX (1.1B). ARZMX (0.51) and SSGSX (0.49) have matching dividends . ARZMX was incepted earlier than SSGSX: ARZMX (8 years) vs SSGSX (27 years). SSGSX (1.26) is less costly to investors than ARZMX (1.02). ARZMX is a more actively managed with annual turnover of: 42.00 vs. SSGSX (37.00). SSGSX has a lower initial minimum investment than ARZMX: SSGSX (2500) vs ARZMX (5000000). ARZMX annual gain was more profitable for investors over the last year : -9.86 vs. SSGSX (-12.62). ARZMX return over 5 years is better than : 31.85 vs. SSGSX (8.71).
ARZMXSSGSXARZMX / SSGSX
Total Expense Ratio1.021.2681%
Annual Report Gross Expense Ratio1.021.2681%
Fund Existence8 years27 years-
Gain YTD0.556-0.129-430%
Front LoadN/A6%-
Min. Initial Investment50000002500200,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.1B5.22B21%
Annual Yield % from dividends0.510.49104%
Returns for 1 year-9.86-12.6278%
Returns for 3 years9.78-6.25-156%
Returns for 5 years31.858.71365%
Returns for 10 yearsN/A20.45-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACRS2.410.11
+4.78%
Aclaris Therapeutics
SONN4.760.16
+3.48%
Sonnet BioTherapeutics Holdings Inc
CRTO22.840.33
+1.47%
Criteo SA
PIPR338.902.44
+0.73%
Piper Sandler Companies
MCK840.75-15.69
-1.83%
McKesson Corp